ImmunoHiTech Revenue
Biotechnology Research • 
Israel • 1-10 Employees
$
ImmunoHiTech revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at ImmunoHiTech
Hanoch Slor
President
Company overview
| Headquarters | Israel |
| Website | |
| NAICS | 541714 |
| Keywords | Immuno-Oncology, Immunotherapy, Monoclonal Antibodies, Targeted Therapy |
| Founded | 2018 |
| Employees | 1-10 |
| Socials |
About ImmunoHiTech
ImmunoHiTech LTD is an Israeli biotech company dedicated to advancing anti-tumor biologics for targeted treatment and prevention of metastatic spread.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Vice President
Funding Data
ImmunoHiTech has never raised funding before.
ImmunoHiTech Tech Stack
Discover the technologies and tools that power ImmunoHiTech's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Performance
United States
Australia
Saudi Arabia
Sweden
Portugal
Frequently asked questions
ImmunoHiTech is located in IL.
ImmunoHiTech generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
ImmunoHiTech has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
ImmunoHiTech was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.
ImmunoHiTech has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
